comparemela.com

Latest Breaking News On - Retina subspecialty day - Page 5 : comparemela.com

Kodiak Sciences Inc. Announces Presentation of Primary Endpoint Data from Tarcocimab Tedromer Phase 3 Glow Study in Patients with Diabetic Retinopathy at American Academy of Ophthalmology Annual Meeting

Kodiak Sciences Inc. announced that data from tarcocimab tedromer will be presented during the annual meeting of the American Academy of Ophthalmology to be held November 3-6, 2023 in San Francisco..

United statesSan franciscoAmerican academy of ophthalmologyKodiak sciences incKodiak sciencesAmerican academyRetina subspecialty dayPrimary endpointKey secondary endpoint

Patients with DME can maintain longer treatment intervals with 8 mg aflibercept

Patients with DME can maintain longer treatment intervals with 8 mg aflibercept
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesDavidm brownByalex youngChristine klimanskisAmerican academy of ophthalmologyAmerican academyRetina subspecialty day

MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results

14.03.2023 - -   Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 -   Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and .

United statesUnited kingdomCity ofJason bracoBotaretigene sparoparvovecAmerican academy of ophthalmology annual meetingLifesci communicationsMeiragtx holdingsEuropean society of geneJanssen pharmaceuticals incJanssen pharmaceutical companies of johnsonAlexandria forbesEuropean societyCell therapyAnnual congressLumeos phase

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.